Human Papillomavirus (HPV)

Recent News

Dec 27, 2017

News Scan for Dec 27, 2017

Saudi MERS case
Yellow fever in Nigeria
South Korean anthrax developments
HPV gender breakdown
Oct 18, 2017

News Scan for Oct 18, 2017

No Seychelles plague cases
Influenza B antibody
HPV vaccine safety
Oct 17, 2017
Man's mouth

Study finds high burden of oral HPV, related cancers in men

HPV-related head and neck cancers are dramatically higher in men than in women.

Sep 20, 2017
Cotton swab and test tube

Study: HPV screen bests Pap smear at detecting cervical cancer

The study involved almost 5,000 women in a country with high vaccine uptake.

Sep 06, 2017
HPV vaccination in Brazil

HPV vaccine may protect against 90% of cervical cancers

Researchers report a 97.4% efficacy for the 9-strain HPV vaccine.

Aug 25, 2017
Teen vaccination

CDC: HPV vaccine rates climb, but disparities exist

Though coverage still isn't optimal, for the first time rates topped 60%, with the boys' level gaining ground on the girls'.

Jun 27, 2017

News Scan for Jun 27, 2017

Antibiotic resistance at the Hajj
MERS in Riyadh
Plague cases
Cat-linked tularemia case
HPV vaccine impact
H5N8 in Belgium
Apr 07, 2017

News Scan for Apr 07, 2017

H9N2 altered in pigs
H7N9 cases in China
US flu decline
Yellow fever vaccine
HPV prevalence
Mar 30, 2017

News Scan for Mar 30, 2017

Brazil microcephaly patterns
MERS in African camels
More E coli cases
Dengue vaccine trial
HPV vaccine in pregnancy
Somalia cholera outbreak
Feb 07, 2017

News Scan for Feb 07, 2017

H7N9 case in China
Bacteremia treatment
HPV vaccine endorsement
Zika blood screening

Resources & Literature

Recent Literature

Alberts CJ, van der Loeff MFS, Hazeveld Y, et al. A longitudinal study on determinants of HPV vaccination uptake in parents/guardians from different ethnic backgrounds in Amsterdam, the Netherlands. BMC Public Health 2017 Feb 21;17:220

Amorim AT, Marques LM, Campos GB, et al. Co-infection of sexually transmitted pathogens and human papillomavirus in cervical samples of women of Brazil. BMC Infect Dis 2017 Dec 15;17:769

Aziz H, Iqbal H, Mahmood H, et al. Human papillomavirus (HPV) infection in females with normal cervical cytology: genotyping and phylogenetic analysis among women in Punjab, Pakistan. Int J Infect Dis 2017 (published online Nov 11)

Bissett SL, Godi A, Jit M, et al. Seropositivity to non-vaccine incorporated genotypes induced by the bivalent and quadrivalent HPV vaccines: a systematic review and meta-analysis. Vaccine 2017 (published online Jun 17)

Bodson J, Wilson A, Warner EL, et al. Religion and HPV vaccine-related awareness, knowledge, and receipt among insured women aged 18-26 in Utah. PLoS One 2017 Aug 25;12(8):e0183725

Canfell K, Caruana M, Gebski V, et al. Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination: results of the Compass pilot randomised trial. PLoS Med 2017 Sep 19;14(9):e1002388

CDC NCHS. Prevalence of HPV in adults aged 18-69: United States, 2011-2014. Apr 6, 2017

Combes JD, Heard I, Poizot-Martin I, et al. Prevalence and risk factors for anal human papillomavirus infection in HIV-positive men having sex with men. J Infect Dis 2018 (published online Jan 31)

Cooper DL, Hernandez ND, Rollins L, et al. HPV vaccine awareness and the association of trust in cancer information from physicians among males. Vaccine 2017 (published online Apr 7)

D'Souza G, McNeel TS, Fakhry C. Understanding personal risk of oropharyngeal cancer: risk-groups for oncogenic oral HPV infection and oropharyngeal cancer. Ann Oncol 2017 (published online Oct 19)

Deshmukh AA, Tanner RJ, Luetke MC, et al. Prevalence and risk of penile HPV infection: evidence from the National Health and Nutrition Examination Survey 2013-14. Clin Infect Dis 2017 (published online Feb 16)

Donken R, King AJ, Bogaards JA, et al. High effectiveness of the bivalent HPV vaccine up to six years post-vaccination against incident and persistent HPV infections in young Dutch females. J Infect Dis 2018 (published online Feb 2)

Eldridge RC, Pawlita M, Wilson L, et al. Smoking and subsequent HPV infection: a mediation analysis. Ann Epidemiol 2017 (published online Oct 17)

Gee J, Sukumaran L, Weintraub E, et al. Risk of Guillain-Barre syndrome following quadrivalent human papillomavirus vaccine in the Vaccine Safety Datalink. Vaccine 2017 (published online Sep 19)

Habbous S, Chu KP, Lau H, et al. Human papillomavirus in oropharyngeal cancer in Canada: analysis of 5 comprehensive cancer centres using multiple imputation. CMAJ 2017 Aug 14;189(32):E1030-40

Hang D, Jia M, Ma H, et al. Independent prognostic role of human papillomavirus genotype in cervical cancer. BMC Infect Dis 2017 Jun 5;17:391

Huang LM, Puthanakit T, Cheng-Hsun C, et al. Sustained immunogenicity of 2-dose human papillomavirus 16/18 AS04-adjuvanted vaccine schedules in girls aged 9-14 years: a randomized trial. J Infect Dis 2017 (published online Jun 7)

Huh WK, Joura EA, Giuliano AR, et al. Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16-26 years: a randomised, double-blind trial. Lancet 2017 (published online Sep 5)

Hviid A, Svanstrom H, Scheller NM, et al. Human papillomavirus vaccination of adult women and risk of autoimmune and neurological diseases. J Intern Med 2017 (published online Oct 18)

Kavanagh K, Pollock KG, Cuschieri K, et al. Changes in the prevalence of human papillomavirus following a national bivalent human papillomavirus vaccination programme in Scotland: a 7-year cross-sectional study. Lancet Infect Dis 2017 (published online Sep 28)

Kjaer SK, Nygard M, Dillner J, et al. A 12-year follow-up on the long-term effectiveness of the quadrivalent human papillomavirus vaccine in 4 Nordic countries. Clin Infect Dis 2017 (published online Oct 1)

Klosky JL, Hudson MM, Chen Y, et al. Human papillomavirus vaccination rates in young cancer survivors. J Clin Oncol 2017 (published online Aug 24)

Kojic EM, Conley L, Bush T, et al. Prevalence and incidence of anal and cervical high-risk human papillomavirus (HPV) types covered by current HPV vaccines among HIV-infected women in the study to understand the natural history of HIV/AIDS in the era of effective therapy (the SUN study). J Infect Dis 2018 (published online Feb 14)

Lehtinen T, Soderlund-Strand A, Petaja T, et al. Human papillomavirus (HPV) prevalence in adolescent males four years post HPV16/18 vaccination. J Infect Dis 2017 (published online Aug 24)

Leung TF, Liu APY, Lim FS, et al. Comparative immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and 4vHPV vaccine administered according to two- or three-dose schedules in girls aged 9-14 years: results to month 36 from a randomized trial. Vaccine 2017 (published online Nov 23)

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»


Unrestricted financial support provided by

Bentson Foundation 3MGilead Become an underwriter»